Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.3 - $6.29 $25,437 - $69,567
-11,060 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.63 - $9.94 $13.5 Million - $29 Million
-2,922,291 Reduced 99.62%
11,060 $63,000
Q4 2021

Feb 14, 2022

BUY
$8.35 - $12.6 $5.28 Million - $7.97 Million
632,172 Added 27.47%
2,933,351 $26.8 Million
Q3 2021

Nov 15, 2021

BUY
$10.13 - $15.0 $8.44 Million - $12.5 Million
833,504 Added 56.79%
2,301,179 $24.6 Million
Q2 2021

Aug 16, 2021

BUY
$13.27 - $18.48 $19.5 Million - $27.1 Million
1,467,675 New
1,467,675 $22.8 Million
Q2 2020

Aug 13, 2020

SELL
$10.89 - $21.47 $5.24 Million - $10.3 Million
-481,608 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$10.23 - $24.56 $4.41 Million - $10.6 Million
431,108 Added 853.68%
481,608 $5.65 Million
Q4 2019

Feb 14, 2020

SELL
$17.42 - $26.61 $925,036 - $1.41 Million
-53,102 Reduced 51.26%
50,500 $1.19 Million
Q3 2019

Nov 14, 2019

SELL
$16.36 - $21.39 $8.4 Million - $11 Million
-513,583 Reduced 83.21%
103,602 $1.92 Million
Q2 2019

Aug 13, 2019

BUY
$16.93 - $26.22 $6.49 Million - $10.1 Million
383,534 Added 164.15%
617,185 $11.5 Million
Q1 2019

May 15, 2019

SELL
$23.15 - $28.34 $2.92 Million - $3.57 Million
-126,062 Reduced 35.05%
233,651 $5.71 Million
Q4 2018

Feb 14, 2019

BUY
$22.03 - $32.01 $1.41 Million - $2.05 Million
64,124 Added 21.69%
359,713 $9.33 Million
Q3 2018

Nov 15, 2018

BUY
$30.0 - $40.85 $1.11 Million - $1.51 Million
37,004 Added 14.31%
295,589 $9.36 Million
Q2 2018

Nov 15, 2018

BUY
$26.4 - $42.0 $6.12 Million - $9.74 Million
231,941 Added 870.52%
258,585 $10 Million
Q2 2018

Aug 14, 2018

SELL
$26.4 - $42.0 $92,109 - $146,538
-3,489 Reduced 11.58%
26,644 $1.04 Million
Q1 2018

May 15, 2018

BUY
$18.43 - $28.8 $555,351 - $867,830
30,133 New
30,133 $832,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $184M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.